Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria
Abstract Rotavirus diarrhoea is associated with high childhood mortality in developing countries. A new vaccine was recently licensed in Mexico. The objective of this study was to assess the effectiveness of routine childhood vaccination by this new vaccine in a developing country. We constructed a...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2007-01, Vol.25 (2), p.298-305 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 305 |
|---|---|
| container_issue | 2 |
| container_start_page | 298 |
| container_title | Vaccine |
| container_volume | 25 |
| creator | Melliez, H Boelle, P.Y Baron, S Mouton, Y Yazdanpanah, Y |
| description | Abstract Rotavirus diarrhoea is associated with high childhood mortality in developing countries. A new vaccine was recently licensed in Mexico. The objective of this study was to assess the effectiveness of routine childhood vaccination by this new vaccine in a developing country. We constructed a decision tree to compare two alternatives: “no vaccination programme” and “vaccination programme”. The estimates used for disease incidence, vaccine efficacy and coverage rates were derived from published data. We followed a hypothetical Nigerian cohort from birth to age five. The vaccine programme would prevent 284,000 cases of rotavirus diarrhoea annually and 6129 deaths due to the disease. In this study in a sub-Saharan country, we showed that rotavirus vaccination with a new vaccine substantially reduces the number of deaths from rotavirus diarrhoea and may be of great use in developing countries. |
| doi_str_mv | 10.1016/j.vaccine.2006.07.038 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00200263v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X06008917</els_id><sourcerecordid>19473951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-d94c77847774822649564cfa3708506c1f3ea442b231b32660d9b622dcf7620b3</originalsourceid><addsrcrecordid>eNqFkl2L1DAUhoso7rj6E5SAKHjRevLdeqEMy-oKg17sCt6FNE23GTvNmrQD--9NaXFgb_YqEJ68Oec8J8teYygwYPFxXxy1MW6wBQEQBcgCaPkk2-BS0pxwXD7NNkAEyxmG32fZixj3AMAprp5nZ1gC55jCJjOXbWvN6I52sDEi3yLTub7pvG_Q8oEenR-QvtVuiCMKftRHF6aI3IDiVOfXutNBD2jbBmf0J3TTWWR0tHPUD3drg9Mvs2et7qN9tZ7n2a-vlzcXV_nu57fvF9tdbjjDY95UzEhZMiklK0kqveKCmVZTCSUHYXBLrWaM1ITimhIhoKlqQUhjWikI1PQ8-7DkdrpXd8EddLhXXjt1td2p-Q4gzYoIesSJfb-wd8H_nWwc1cFFY_teD9ZPUYmSSobZ4yCumKQVn8G3D8C9n8KQGlaYM4kZFxVPFF8oE3yMwbb_C8WgZrFqr1axaharQKokNr17s6ZP9cE2p1eryQS8WwEdje7b5MS4eOJKlkbKaeK-LJxNJo7OBhWNs4OxjQtpEVTj3aOlfH6QYHo3JPn9H3tv46lrFYkCdT1v4byEIADKCkv6D0R-1WQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547145695</pqid></control><display><type>article</type><title>Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Melliez, H ; Boelle, P.Y ; Baron, S ; Mouton, Y ; Yazdanpanah, Y</creator><creatorcontrib>Melliez, H ; Boelle, P.Y ; Baron, S ; Mouton, Y ; Yazdanpanah, Y</creatorcontrib><description>Abstract Rotavirus diarrhoea is associated with high childhood mortality in developing countries. A new vaccine was recently licensed in Mexico. The objective of this study was to assess the effectiveness of routine childhood vaccination by this new vaccine in a developing country. We constructed a decision tree to compare two alternatives: “no vaccination programme” and “vaccination programme”. The estimates used for disease incidence, vaccine efficacy and coverage rates were derived from published data. We followed a hypothetical Nigerian cohort from birth to age five. The vaccine programme would prevent 284,000 cases of rotavirus diarrhoea annually and 6129 deaths due to the disease. In this study in a sub-Saharan country, we showed that rotavirus vaccination with a new vaccine substantially reduces the number of deaths from rotavirus diarrhoea and may be of great use in developing countries.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>EISSN: 0264-410X</identifier><identifier>DOI: 10.1016/j.vaccine.2006.07.038</identifier><identifier>PMID: 17055130</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Applied microbiology ; Biological and medical sciences ; Child, Preschool ; Children & youth ; Developing countries ; Diarrhea ; Economics and Finance ; Fundamental and applied biological sciences. Psychology ; Humanities and Social Sciences ; Humans ; Infant ; Infant, Newborn ; LDCs ; Life Sciences ; Microbiology ; Miscellaneous ; Mortality ; Nigeria ; Rotavirus ; Rotavirus mortality ; Rotavirus vaccine ; Rotavirus Vaccines - immunology ; Santé publique et épidémiologie ; Sub-Saharan Africa ; Vaccination ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Virology</subject><ispartof>Vaccine, 2007-01, Vol.25 (2), p.298-305</ispartof><rights>Elsevier Ltd</rights><rights>2006 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 4, 2007</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-d94c77847774822649564cfa3708506c1f3ea442b231b32660d9b622dcf7620b3</citedby><cites>FETCH-LOGICAL-c541t-d94c77847774822649564cfa3708506c1f3ea442b231b32660d9b622dcf7620b3</cites><orcidid>0000-0002-5367-8232</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1547145695?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18422653$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17055130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00200263$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Melliez, H</creatorcontrib><creatorcontrib>Boelle, P.Y</creatorcontrib><creatorcontrib>Baron, S</creatorcontrib><creatorcontrib>Mouton, Y</creatorcontrib><creatorcontrib>Yazdanpanah, Y</creatorcontrib><title>Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Rotavirus diarrhoea is associated with high childhood mortality in developing countries. A new vaccine was recently licensed in Mexico. The objective of this study was to assess the effectiveness of routine childhood vaccination by this new vaccine in a developing country. We constructed a decision tree to compare two alternatives: “no vaccination programme” and “vaccination programme”. The estimates used for disease incidence, vaccine efficacy and coverage rates were derived from published data. We followed a hypothetical Nigerian cohort from birth to age five. The vaccine programme would prevent 284,000 cases of rotavirus diarrhoea annually and 6129 deaths due to the disease. In this study in a sub-Saharan country, we showed that rotavirus vaccination with a new vaccine substantially reduces the number of deaths from rotavirus diarrhoea and may be of great use in developing countries.</description><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Child, Preschool</subject><subject>Children & youth</subject><subject>Developing countries</subject><subject>Diarrhea</subject><subject>Economics and Finance</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>LDCs</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Mortality</subject><subject>Nigeria</subject><subject>Rotavirus</subject><subject>Rotavirus mortality</subject><subject>Rotavirus vaccine</subject><subject>Rotavirus Vaccines - immunology</subject><subject>Santé publique et épidémiologie</subject><subject>Sub-Saharan Africa</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Virology</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>0264-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkl2L1DAUhoso7rj6E5SAKHjRevLdeqEMy-oKg17sCt6FNE23GTvNmrQD--9NaXFgb_YqEJ68Oec8J8teYygwYPFxXxy1MW6wBQEQBcgCaPkk2-BS0pxwXD7NNkAEyxmG32fZixj3AMAprp5nZ1gC55jCJjOXbWvN6I52sDEi3yLTub7pvG_Q8oEenR-QvtVuiCMKftRHF6aI3IDiVOfXutNBD2jbBmf0J3TTWWR0tHPUD3drg9Mvs2et7qN9tZ7n2a-vlzcXV_nu57fvF9tdbjjDY95UzEhZMiklK0kqveKCmVZTCSUHYXBLrWaM1ITimhIhoKlqQUhjWikI1PQ8-7DkdrpXd8EddLhXXjt1td2p-Q4gzYoIesSJfb-wd8H_nWwc1cFFY_teD9ZPUYmSSobZ4yCumKQVn8G3D8C9n8KQGlaYM4kZFxVPFF8oE3yMwbb_C8WgZrFqr1axaharQKokNr17s6ZP9cE2p1eryQS8WwEdje7b5MS4eOJKlkbKaeK-LJxNJo7OBhWNs4OxjQtpEVTj3aOlfH6QYHo3JPn9H3tv46lrFYkCdT1v4byEIADKCkv6D0R-1WQ</recordid><startdate>20070104</startdate><enddate>20070104</enddate><creator>Melliez, H</creator><creator>Boelle, P.Y</creator><creator>Baron, S</creator><creator>Mouton, Y</creator><creator>Yazdanpanah, Y</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>BXJBU</scope><orcidid>https://orcid.org/0000-0002-5367-8232</orcidid></search><sort><creationdate>20070104</creationdate><title>Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria</title><author>Melliez, H ; Boelle, P.Y ; Baron, S ; Mouton, Y ; Yazdanpanah, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-d94c77847774822649564cfa3708506c1f3ea442b231b32660d9b622dcf7620b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Child, Preschool</topic><topic>Children & youth</topic><topic>Developing countries</topic><topic>Diarrhea</topic><topic>Economics and Finance</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>LDCs</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Mortality</topic><topic>Nigeria</topic><topic>Rotavirus</topic><topic>Rotavirus mortality</topic><topic>Rotavirus vaccine</topic><topic>Rotavirus Vaccines - immunology</topic><topic>Santé publique et épidémiologie</topic><topic>Sub-Saharan Africa</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melliez, H</creatorcontrib><creatorcontrib>Boelle, P.Y</creatorcontrib><creatorcontrib>Baron, S</creatorcontrib><creatorcontrib>Mouton, Y</creatorcontrib><creatorcontrib>Yazdanpanah, Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melliez, H</au><au>Boelle, P.Y</au><au>Baron, S</au><au>Mouton, Y</au><au>Yazdanpanah, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2007-01-04</date><risdate>2007</risdate><volume>25</volume><issue>2</issue><spage>298</spage><epage>305</epage><pages>298-305</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><eissn>0264-410X</eissn><coden>VACCDE</coden><abstract>Abstract Rotavirus diarrhoea is associated with high childhood mortality in developing countries. A new vaccine was recently licensed in Mexico. The objective of this study was to assess the effectiveness of routine childhood vaccination by this new vaccine in a developing country. We constructed a decision tree to compare two alternatives: “no vaccination programme” and “vaccination programme”. The estimates used for disease incidence, vaccine efficacy and coverage rates were derived from published data. We followed a hypothetical Nigerian cohort from birth to age five. The vaccine programme would prevent 284,000 cases of rotavirus diarrhoea annually and 6129 deaths due to the disease. In this study in a sub-Saharan country, we showed that rotavirus vaccination with a new vaccine substantially reduces the number of deaths from rotavirus diarrhoea and may be of great use in developing countries.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17055130</pmid><doi>10.1016/j.vaccine.2006.07.038</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5367-8232</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2007-01, Vol.25 (2), p.298-305 |
| issn | 0264-410X 1873-2518 0264-410X |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00200263v1 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Allergy and Immunology Applied microbiology Biological and medical sciences Child, Preschool Children & youth Developing countries Diarrhea Economics and Finance Fundamental and applied biological sciences. Psychology Humanities and Social Sciences Humans Infant Infant, Newborn LDCs Life Sciences Microbiology Miscellaneous Mortality Nigeria Rotavirus Rotavirus mortality Rotavirus vaccine Rotavirus Vaccines - immunology Santé publique et épidémiologie Sub-Saharan Africa Vaccination Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Virology |
| title | Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A24%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20childhood%20vaccination%20against%20rotavirus%20in%20sub-Saharan%20Africa:%20The%20case%20of%20Nigeria&rft.jtitle=Vaccine&rft.au=Melliez,%20H&rft.date=2007-01-04&rft.volume=25&rft.issue=2&rft.spage=298&rft.epage=305&rft.pages=298-305&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2006.07.038&rft_dat=%3Cproquest_hal_p%3E19473951%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547145695&rft_id=info:pmid/17055130&rft_els_id=S0264410X06008917&rfr_iscdi=true |